Active Ingredient History
Tropicamide (Mydriacyl) is an anticholinergic used as a mydriatic.Tropicamide belongs to the group of medicines called anti-muscarinics. Tropicamide blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. By blocking these receptors, tropicamide produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia). Tropicamide is given as eye drops to dilate the pupil and relax the lens so that eye examinations can be carried out thoroughly. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Eye Diseases (approved 1960)
Anisocoria (Phase 4)
Cataract (Phase 4)
Corneal Endothelial Cell Loss (Phase 3)
Corneal Transplantation (Phase 4)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Esotropia (Phase 4)
Eye Diseases (Phase 4)
Infant, Premature (Phase 4)
Intraocular Pressure (Phase 4)
Mydriasis (Phase 4)
Myopia (Phase 4)
Parkinson Disease (Phase 2)
Premature Birth (Phase 3)
Refractive Errors (Phase 4)
Retinal Diseases (Phase 3)
Retinopathy of Prematurity (Phase 4)
Sialorrhea (Phase 2)
Vision Disorders (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
